Professional Services: Domain and data science expertise to tackle complex challenges

Develop custom algorithms and apply machine learning to create an integrated and harmonized source of data. Elsevier can help with:

• Data integration and harmonization

• Workflow solutions

• Text-mining applications

• Cheminformatics

Develop custom reports to answer key R&D and safety questions. Elsevier can help answer questions such as:

• Which studies have been conducted for similar compounds and what were the findings?

• What adverse events might occur based on molecular structure and class?

• What are the most predictive preclinical species for understanding human toxicity?

• What is the potential risk of litigation based on drug failure?

Accelerate early discovery activities through access to critical disease or target overview information to prioritize research focus areas. Elsevier can help you answer key research questions, such as:

• Which diseases might this target treat?

• What are the potential adverse events and drug interactions?

• Are there known molecules likely to be test molecules?

• What new target may exist to treat a specific disease with less side effects?

• How does each target score based on pathway activation, gene expression, and an overall literature analysis?

Develop a more thorough understanding of the chemical risk of a compound based on the analysis of biological pathways in the human body and underlying molecular mechanisms that can cause diseases. Our team can help answer questions such as:

• What are the key cells to target for a particular disease?

• Which proteins are relevant in my disease of interest?

• What are the biomarkers on the path to toxicity?

• Which molecular mechanisms are linked to disease outcomes?

Access detailed custom reports and predictive analytics to support critical drug repurposing decisions. These solutions include:

• Text mining for possible drug indications in the scientific literature

• Prediction of new drug indications based on drug target biology and efficacy of other drugs in the same class

• Scoring mechanism to identify most promising repurposing candidates

Disease-centric repurposing includes pathway analysis to identify:

• Signaling affected in a disease

• Compounds targeting proteins in the disease pathway

• Known drugs to inhibit proteins

엘스비어의 전문 서비스와 솔루션 포트폴리오를 통해 R&D를 발전시켜 혁신 성과를 지원하고 최적화하십시오. 다음과 같은 지원을 통해 자신 있게 R&D 여정을 진행하십시오.

• 동료 심사를 거친 과학 문헌에서 규제 데이터에 이르기까지 신뢰할 수 있는 콘텐츠

• 기계 소비를 위해 데이터를 준비하는 혁신적인 기술

• 컴퓨팅 형식으로 과학적 지식을 캡처할 수 있는 전문 지식

정보 무결성은 진행에 필수적입니다. 복잡성을 과학적 통찰력으로 전환하는 신뢰할 수 있는 데이터와 도구를 살펴보세요. 함께 발전을 이루어 나갑시다.